All Patients on Chronic Opioid Therapy Should Be Co-Prescribed Naloxone: Expert

All patients on long-term opioid treatment should be co-prescribed the opioid overdose antidote naloxone, even if they are not considered to be at high risk of an opioid overdose, according to the director of the University of New Mexico Pain Center.

Patients on long-term opioids should be co-prescribed naloxone because the risk of opioid overdose can change quickly, says Joanna Katzman, M.D. “You never know when someone will go from low risk to medium risk to high risk, especially in the chronic pain population. A person can be on a stable dose of opiates and then develop a condition that depresses breathing, such as pneumonia, sleep apnea or a fever. Because opiates also depress breathing, suddenly they are at risk.” Or a person may go to the hospital and receive a higher dose of opiates from a physician than what they are already on, increasing their risk of an overdose, Dr. Katzman noted.

“We think naloxone should be supplied by clinicians liberally, and also should be in the hands of law enforcement and emergency medical services,” she said. She added that many patients who die of an unintentional opiate overdose get the drugs from a family member or friend instead of their health care provider.

Dr. Katzman published a study earlier this year in the journal Substance Abuse that included 164 patients taking long-term opioids for non-cancer pain, who were also prescribed naloxone. They and their families were educated about the risks and signs of an opioid overdose. They were provided naloxone rescue kits, and family members were shown how to use it. No overdoses occurred among the patients in the study.

“We showed we can teach patients and family how to use opiates safely and how to use naloxone,” Dr. Katzman said. “We also found patients did not think we considered them drug users because we were giving them naloxone. They appreciated that we were caring for them more safely.”

According to guidelines for prescribing opioids for chronic pain, issued earlier this year by the Centers for Disease Control and Prevention, most experts agreed that clinicians should consider offering naloxone when prescribing opioids to patients at increased risk for overdose, including patients with a history of overdose, patients with a history of substance use disorder, patients taking benzodiazepines with opioids, patients at risk for returning to a high dose to which they are no longer tolerant (such as patients recently released from prison), and patients taking higher dosages of opioids. Dr. Katzman says those recommendations should go a step further, by providing naloxone to all patients on chronic opioid therapy, regardless of whether they are considered high risk.

Naloxone is becoming easier to buy around the country. Most states have passed laws allowing people to buy naloxone without a prescription. Drugstores and other retailers are also making it more easily available. Until recently, naloxone, sold as Narcan, was available mostly through clinics, hospitals or paramedics and other first responders.

Dr. Katzman is now conducting a study of patients enrolled at the University of New Mexico’s Addiction Clinic who have opioid substance use disorder. The patients, who are being treated with either methadone or buprenorphine, are also given a handheld device called Evzio that delivers a single dose of naloxone. “We’ve enrolled almost 300 patients so far, and we already have seen that many lives have been saved so far,” she said. Dr. Katzman hopes to publish the results soon.

People being treated for opioid addiction are at greatest risk of overdose in the first days after they begin treatment with medication-assisted treatment. Dr. Katzman said many studies have shown that co-prescribing naloxone with opioids does not increase the misuse of prescription opioids or heroin. “Some people think that by handing out naloxone, it will encourage people to use more drugs. Many studies have disproved that. I think opioid substance use disorder treatment centers should be required to co-prescribe ‘take-home’ naloxone in their programs.”

    User Picture

    …..should not throw stones

    October 20, 2017 at 2:38 AM

    Seems to me the ones who win here are the Drug companies. The assumption that you need this drug to prevent the abuse of another one.
    Take a pill to wake and a pill to go to sleep.

    User Picture

    Justine K Kinealy

    December 20, 2016 at 11:03 AM

    The people who are overdosing are the kid’s looking for the high not the one prescribed for genuine pain….

    User Picture

    T. A. Bower

    December 17, 2016 at 12:08 PM

    “All patients on chronic opioid therapy should be prescribed naloxone”? Why such a grossly irresponsible headline from one source? If you would please talk to chronic pain patients, you would discover the increased contempt for their problems, barriers to “care”, in the name of preventing overdose, or god forbid, addiction. Chronic pain patients are suffering increases in their burden of illness, not because of their actions or illness but because of the opioid crisis that has nothing to do with them. Placing this headline first supports the burgeoning search for simplistic answers to addiction. It distracts from the complexity of human beings and the difficulty of finding a “cure”. Leave the chronic pain patients out of this discussion. My sister suffered a debilitating and currently incurable nerve damage which effectively ended her brilliant career and doomed her to disability. The worst part of it is the medical arrogance and lack of concern for her as a human suffering. Stigma is pervasive.

      User Picture

      Jenny

      August 22, 2017 at 11:12 PM

      Yes!!!! Absolutely!!! I, too have chronic pain issues, partially due to the fact that when I started complaining of severe back and leg pain, it took almost a year and four different physicians for someone to take me seriously enough to investigate further. I am an educated, professional, mother of 4 and have no history of addiction whatsoever. By the time I was finally diagnosed, my spinal cord had been compressed in to 1/10th the space it should be in. I required emergency decompression surgery and I have permanent nerve damage now. I have tried numerous therapies, but I will probably always need opiates to function. I deal with the stigma constantly. Pharmacists give me crap, some of the mothers of my kids friends will not allow their children to be at my house unless my husband is home as well (there is absolutely no reason for this), even some of my family members send me info on drug rehab places bc they know I take opiates. This isn’t what my life is supposed to be like. Thank you for standing up for us!

    User Picture

    Nikki JOHNSON

    December 15, 2016 at 4:00 PM

    This idea doubly rewards the pharmaceutical companies that both made and dishonestly marketed some long acting opiates. Being great a business, the same company who produces the most abused opiates also produces naloxone. There are three faulty assumptions in this “solution”. First, the data indicates that people who use naloxone for overdose, are more likely to overdose again. Second, opiates are known to at some point in use to actually make pain worse, hyperalgesia. Third, the assumption that all people who are on pain meds need to be one them forever, is another symptom of a profit driven health care system where prescriptions are efficient practice, or as we like to say “the practice of medicine has now become medicine.” Offering treatment for opiate addiction beside more opiates, has a been ignored in this plan as a way to keep people from overdosing and return to a higher level of functioning, physically and emotionally. Ask people who have benefitted from non-drug approaches.

Leave a Reply

Your email address will not be published. Required fields are marked *